Generating improved single-chain Fv molecules for tumor targeting.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1999-12-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0022-1759(99)00161-1PMID 10648942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.

  1999cited by this paper
• Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives.

  1998cited by this paper
• Improving the tumor specificity and retention of antibody-based molecules.

  1998cited by this paper
• Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments

  1998cited by this paper
• Improving the tumor specificity and retention of antibody-based molecules.

  1998cited by this paper
• A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries.

  1998cited by this paper
• Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens.

  1998cited by this paper
• A dimeric bispecific miniantibody combines two specificities with avidity

  1998cited by this paper
• The next frontier of molecular medicine: Delivery of therapeutics

  1998cited by this paper
• Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.

  1998cited by this paper
• Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection.

  1998cited by this paper
• Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries.

  1998cited by this paper
• Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.

  1998cited by this paper
• Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.

  1997cited by this paper
• Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections.

  1997cited by this paper
• A model system for detection and isolation of a tumor cell surface antigen using antibody phage display.

  1997cited by this paper
• Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma.

  1997cited by this paper
• FcRn: the MHC class I-related receptor that is more than an IgG transporter.

  1997cited by this paper
• In vitro selection and evolution of functional proteins by using ribosome display.

  1997cited by this paper
• Triabodies: single chain Fv fragments without a linker form trivalent trimers

  1997cited by this paper
• Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies

  1997cited by this paper
• Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library

  1996cited by this paper
• Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

  1996cited by this paper
• Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

  1996cited by this paper
• Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain.

  1996cited by this paper
• Affinity maturation of recombinant antibodies using E. coli mutator cells.

  1996cited by this paper
• Identification of functional and structural amino-acid residues by parsimonious mutagenesis.

  1996cited by this paper
• Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.

  1996cited by this paper
• Generation of a panel of related human scFv antibodies with high affinities for human CEA.

  1996cited by this paper
• Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.

  1996cited by this paper
• Construction and evolution of antibody–phage libraries by DMA shuffling

  1996cited by this paper
• In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.

  1995cited by this paper
• Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library.

  1995cited by this paper
• VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor V alpha.

  1995cited by this paper
• Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

  1995cited by this paper
• CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.

  1995cited by this paper
• VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor Vα

  1995cited by this paper
• Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions.

  1995cited by this paper
• Making antibodies by phage display technology.

  1994cited by this paper
• Isolation of high affinity human antibodies directly from large synthetic repertoires.

  1994cited by this paper
• Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.

  1994cited by this paper
• Rapid evolution of a protein in vitro by DNA shuffling

  1994cited by this paper
• "Diabodies": small bivalent and bispecific antibody fragments.

  1993cited by this paper
• Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.

  1993cited by this paper
• Antibody engineering by parsimonious mutagenesis.

  1993cited by this paper
• By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling

  1992cited by this paper
• By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro.

  1992cited by this paper
• Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

  1992cited by this paper
• Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.

  1992cited by this paper
• Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

  1992cited by this paper
• Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.

  1992cited by this paper
• By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

  1991cited by this paper
• Making antibody fragments using phage display libraries

  1991cited by this paper
• Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.

  1991cited by this paper
• In vivo tumor targeting of a recombinant single-chain antigen-binding protein.

  1990cited by this paper
• Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.

  1989cited by this paper
• Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.

  1988cited by this paper
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

  1988cited by this paper
• Single-chain antigen-binding proteins.

  1988cited by this paper
• The Pharmacology of Monoclonal Antibodies a

  1987cited by this paper
• Isoelectric point of albumin: effect on renal handling of albumin.

  1979cited by this paper
• Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

  1979cited by this paper
• Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran.

  1975cited by this paper

• A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies.

  2024cites this paper
• Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma

  2018cites this paper
• Screening for single-chain variable fragment antibodies against multiple Cry1 toxins from an immunized mouse phage display antibody library

  2018cites this paper
• Screening for single-chain variable fragment antibodies against multiple Cry1 toxins from an immunized mouse phage display antibody library

  2018cites this paper
• Targeting molecules for diagnostics of Head and Neck squamous cell carcinoma

  2017cites this paper
• Effects of metal ions on the structure and activity of a human anti-cyclin D1 single-chain variable fragment AD5

  2017cites this paper
• Construction, expression and characterization of a fusion protein HBscFv-IFNγ in Komagatella (Pichia) pastoris X33.

  2017cites this paper
• Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image‐Guided Approaches

  2016cites this paper
• Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studies.

  2016cites this paper
• Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.

  2016cites this paper
• Selections for Enzymatic Catalysts

  2015cites this paper
• Antibody Conjugates via Disulfide Bridging: Towards therapeutic and diagnostic applications

  2015cites this paper
• Theranostic Nanoparticles Carrying Doxorubicin Attenuate Targeting Ligand Specific Antibody Responses Following Systemic Delivery

  2015cites this paper
• β-Conglutin dual aptamers binding distinct aptatopes

  2015cites this paper
• Development of inhalable microparticles for drug delivery to deep lung tissues

  2015cites this paper
• Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85.

  2015cites this paper
• The quest for a general co-crystallization strategy for macromolecules: lessons on the use of chaperones for membrane protein crystallization

  2015cites this paper
• Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization

  2015cites this paper
• Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization.

  2015cites this paper
• Challenges for Therapeutic Application of Pseudomonas Exotoxin-Based Immunotoxins

  2015cites this paper
• Resistance to Immunotoxins in Cancer Therapy

  2015cites this paper
• Generierung Plasmodium falciparum-spezifischer humaner Antikörperformate aus Epstein-Barr Virus-transformierten B Lymphozyten semi-immuner Individuen

  2015cites this paper
• Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis

  2014cites this paper
• Pharmacokinetic and pharmacodynamic challenges of Antibody-Directed Enzyme Prodrug Therapy (ADEPT)

  2014cites this paper
• Improved ligand binding by antibody-aptamer pincers.

  2014cites this paper
• Construction and Expression of a Novel Anti-CD14 Human-Mouse Chimeric Antibody Hm2F9

  2014cites this paper
• Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis

  2014cites this paper
• High scFv-receptor affinity does not enhance the antitumor activity of HER2 retargeted measles virus

  2014cites this paper
• Generation of Recombinant Antibodies to Rat GABAA Receptor Subunits by Affinity Selection on Synthetic Peptides

  2014cites this paper
• Selection of Potential Therapeutic Human Single-Chain Fv Antibodies against Cholecystokinin-B/Gastrin Receptor by Phage Display Technology

  2013cites this paper
• Expression and purification of a human anti-cyclin D1 single-chain variable fragment antibody AD5 and its characterization.

  2013cites this paper
• Expression and Characterization of Recombinant Interleukin-21 Receptor and Its Targeting Single-Chain Variable Fragment Antibodies Selected from a Human Phage Display Library

  2012cites this paper
• Synthetic antibodies: concepts, potential and practical considerations.

  2012cites this paper
• Generation and analysis of mutated clonal scFv antibody fragments against R7V epitope of HIV-1

  2012cites this paper
• Antibody-conjugated nanoparticles for therapeutic applications.

  2012cites this paper
• CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Typesof Tumors

  2012cites this paper
• Construction of divalent anti-keratin 8 single-chain antibodies (sc(Fv)(2)), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids.

  2011cites this paper
• Protein-based tumor molecular imaging probes

  2011cites this paper
• Nano-sensitizers for multi-modality optical diagnostic imaging and therapy of cancer

  2011cites this paper
• The αvβ6 Integrin in cancer

  2011cites this paper
• Immunoassays in agricultural biotechnology.

  2011cites this paper
• Construction and Characterization of Single-Chain Variable Fragment Antibody Library Derived from Germline Rearranged Immunoglobulin Variable Genes

  2011cites this paper
• Aptamer Conjugates: Emerging Delivery Platforms for Targeted Cancer Therapy

  2011cites this paper
• CLONAGEM E EXPRESSÃO DE UM FRAGMENTO VARIÁVEL EM CADEIA ÚNICA CONTRA A TOXINA TERMO-LÁBIL DE Escherichia coli ENTEROTOXIGÊNICA

  2011cites this paper
• Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

  2011cites this paper
• A Single-Chain Antibody Fragment Against Human Thyroglobulin: Construction and Evaluation of Immunoreactivity

  2011cites this paper
• Interfacial complexation reactions of Sr2+ with octyl(phenyl)-N,N-diisobutylcarbamoylmethylphosphine oxide for understanding its extraction in reprocessing spent nuclear fuels.

  2011cites this paper
• Antibody targeted nanoparticles for imaging and therapy of cancer

  2010cites this paper
• PEGylation of Antibody Fragments to Improve Pharmacodynamics and Pharmacokinetics

  2010influential citation
• Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer

  2010cites this paper
• Highly Enhanced Cytotoxicity of a Dimeric Bispecific Diabody, the hEx3 Tetrabody*

  2010cites this paper
• Antibody Engineering in Agricultural Biotechnology

  2010cites this paper
• Preclinical Safety Evaluation of Immunotoxins

  2010cites this paper
• Construction of scFv phage display library with hapten-specific repertories and characterization of anti-ivermectin fragment isolated from the library

  2010cites this paper
• Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement.

  2010cites this paper
• Doomsday Book, Vol. II

  2009cites this paper
• Engineering recombinant chicken antibodies for improved characteristics

  2009cites this paper
• Combinatorial Libraries of Arrayable Single-Chain Antibodies

  2009cites this paper
• Intrabody and Parkinson's disease.

  2009cites this paper
• Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus

  2008cites this paper
• Evolution of phage display: from bioactive peptides to bioselective nanomaterials

  2008cites this paper
• Evolution of phage display: from bioactive peptides to bioselective nanomaterials.

  2008cites this paper
• Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

  2008cites this paper
• Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML)

  2008cites this paper
• Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct

  2008cites this paper
• Improvement of Aptamer Affinity by Dimerization

  2008cites this paper
• Complement as effector system in cancer immunotherapy.

  2007cites this paper
• Isolation and affinity maturation of hapten-specific antibodies.

  2007cites this paper
• In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab.

  2007cites this paper
• Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent.

  2007cites this paper
• Antibody‐based Proteomics: From bench to bedside

  2007cites this paper
• A33scFv-green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting.

  2007cites this paper
• An inductively coupled plasma mass spectrometry method for the quantification of yttrium-antibody based drugs using stable isotope tracing.

  2007cites this paper
• Phage display of chelating recombinant antibody libraries.

  2007cites this paper
• Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.

  2007cites this paper
• General principles of tumor immunotherapy : basic and clinical applications of tumor immunology

  2007cites this paper
• Chapter 2 – Principles of the Immune System Central to Transfusion Medicine

  2007cites this paper
• Monoclonal Antibodies in Cancer Therapy

  2007cites this paper
• Recombinant antibodies and tumor targeting

  2006cites this paper
• PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5

  2006cites this paper
• Antibodies with infinite affinity: origins and applications.

  2006cites this paper
• Antiangiogenic peptides and proteins: from experimental tools to clinical drugs.

  2006cites this paper
• Latest technologies for the enhancement of antibody affinity.

  2006cites this paper
• MONOCLONAL ANTIBODIES AS TARGETING AND THERAPEUTIC AGENTS: PROSPECTS FOR LIVER TRANSPLANTATION, HEPATITIS AND HEPATOCELLULAR CARCINOMA

  2006cites this paper
• Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.

  2006cites this paper
• Screening phage display libraries for organ-specific vascular immunotargeting in vivo.

  2006cites this paper
• Lactobacilli expressing antibody fragments against pathogens

  2006cites this paper
• Codon optimization, expression, and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris.

  2006cites this paper
• The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

  2006cites this paper
• Single chain antibodies against the 37 kDa/67 kDa laminin receptor as tools for prion diseases therapy

  2006cites this paper
• Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.

  2005cites this paper
• Improving outcome in melanoma by early detection and identification of novel prognostic markers.

  2005cites this paper
• Antibody phage display technologies with special reference to angiogenesis

  2005cites this paper
• Protein PEGylation Decreases Observed Target Association Rates via a Dual Blocking Mechanisms⃞

  2005cites this paper
• The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

  2005cites this paper
• Engineering and functional evaluation of a single‐chain antibody against HIV‐1 external glycoprotein gp120

  2005cites this paper
• Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement‐regulatory proteins CD55 and CD59

  2005cites this paper
• Targeted for drug delivery

  2005cites this paper
• Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass.

  2005cites this paper
• A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

  2005cites this paper